Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor [Phase 1]

View source ↗

Summary

A Phase 1 study completed evaluating the safety and pharmacokinetics of two formulations of C1-esterase inhibitor for hereditary angioedema, sponsored by CSL Be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: CSL Behring | Conditions: Hereditary Angioedema Types I and II | Phase 1 | Status: COMPLETED